Our Mission

The UK DRI Centre at Imperial is well aligned with the mission of the UK DRI to pursue innovative, early-stage science advancing an understanding of how dementias develop. We are working to translate our new discoveries into new therapies. Our innovation comes from our highly interdisciplinary team. We make a unique contribution to the UK DRI with remit that integrates large population ‘omics studies with multi-omic neuropathology to discover how genetics, environment and lifestyle together initiate the cellular phases of Alzheimer’s (AD) and Parkinson’s (PD) diseases and how these can be modulated therapeutically.

By planning and executing our science openly and collaboratively with that in other Centres across the UK DRI, we are achieving more and doing so more confidently and quickly.